Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,994 public trials 1,209 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Recruiting

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

NCT03686124

Conditions
Adnexal Diseases, Cancer, Disease Attributes, +35 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States
  • University of Miami Hospital and Clinics Miami, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 21 locations
View Trial Details
Recruiting

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

NCT05492682

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +44 more
Locations
  • Krankenhaus Nordwest Frankfurt, Germany
  • National Center for Tumor Diseases Heidelberg, Germany
  • Universitätsklinikum Tübingen Tübingen, Germany
  • Istituto di Candiolo Fondazione del Piemonte per l'oncologia IRCCS Candiolo, Italy
View Trial Details
Recruiting

LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma

NCT06623461

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • BCCA - Abbotsford Abbotsford British Columbia, British Columbia, Canada
  • BCCA - Surrey Surrey, British Columbia, Canada
  • BCCA - Vancouver Vancouver, British Columbia, Canada
  • Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
View all 14 locations
View Trial Details
Recruiting

Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.

NCT05918302

Conditions
Hemic and Lymphatic Diseases, Lung Neuroendocrine Neoplasm, Lymphatic Diseases, +9 more
Locations
  • Antwerp University Hospital (UZA) Edegem, Belgium
  • UCL Saint-Luc Brussels, Belgium
  • CHU Liège Liège, Belgium
  • Hospital Center University Dijon Bourgogne (CHU Bourgogne) Dijon, France
View all 27 locations
View Trial Details
Recruiting

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

NCT05096481

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +19 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View all 13 locations
View Trial Details

Related conditions